Skip to main content

Morristown Medical Center: Leading Edge Research in CAR-T and TIL therapy

Thanks in part to a partnership with the Translational Genomics Research Institute (TGen) of Phoenix, Arizona via the Breakthrough Oncology Accelerator, Morristown Medical Center now offers patients access to innovative clinical trials for immunotherapies including the use of Chimeric Antigen Receptor T Cells (CAR-T) and Tumor Infiltrating Lymphocytes (TIL).

Patients undergoing intensive chemotherapy or immunotherapy for the treatment of blood cancers are particularly vulnerable to treatment-related side effects and require heightened monitoring and management. That is why Morristown Medical Center is also pleased to announce the creation of the Beckman Advanced Cellular Therapy Unit to help ensure the highest quality care and best outcomes for this complex patient population.

The Beckman Advanced Cellular Therapy Unit will safely expand access to these CAR-T and TIL therapies and is equipped with state-of-the-art hemodynamic monitoring technology and staffed with highly trained nurses to deliver the safest possible treatment.

“The Atlantic Cellular Therapy program is committed to providing our patients with the safest possible access to the latest advancements in clinical care and the Beckman Advanced Cellular Therapy Unit is a powerful step forward in fulfilling that commitment,” said Mohamad Cherry, MD, Medical Director, Hematology/Oncology and Medical Director, Atlantic Cellular Therapy Program. “It also helps drive the science of expanding these treatments to new cancers and we are incredibly proud to be at the forefront of this work on behalf of cancer patients worldwide.”

“Morristown Medical Center is proud to be at the leading edge of the latest, advanced science in the care of blood cancers including leukemia, lymphoma and myeloma, but caring for these patients requires a special combination of resources and expertise” Eric D. Whitman, MD, System Medical Director, Atlantic Health System Cancer Care and Director, Atlantic Melanoma Center. “Through the creation of the Beckman Advanced Cellular Therapy Unit, Morristown Medical Center joins an elite level of hospitals providing this potentially lifesaving care.”